tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 362 are a BUY (95.51%), 7 are a SELL (1.85%), 10 are a HOLD (2.64%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 39.1% that have a potential upside of 45.66% achieved within 213 days.
Leland Gershell’s has documented 723 price targets and ratings displayed on 57 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on ARGX, argenx NV ADR at 11-Oct-2026.
Analyst best performing recommendations are on BXRX (BAUDAX BIO).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/23/2024. The price target of $15 was fulfilled within 7 days with a profit of $9.03 (151.26%) receiving and performance score of 216.08.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Dec-2022
$12
$8.63 (256.08%)
$12
2 years 25 days ago
(26-Sep-2024)
1/3 (33.33%)
$8.93 (290.88%)
3
Buy Since 26-Sep-2024
$8
$4.63 (137.39%)
2 years 25 days ago
(26-Sep-2024)
0/1 (0%)
$4.93 (160.59%)
Buy
$2.5
$-0.28 (-10.07%)
3 years 8 months 6 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy Since 18-Jul-2019
$29.41
$26.04 (772.70%)
$30
4 years 3 months 29 days ago
(22-Jun-2022)
0/5 (0%)
$24 (443.62%)
Buy Since 09-Jul-2019
$12
$8.63 (256.08%)
$144
6 years 1 months 19 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Which stock is Leland Gershell most bullish on?
Which stock is Leland Gershell most reserved on?
What Year was the first public recommendation made by Leland Gershell?
